IL18 and colitis: In the dextran sulfate sodium (DSS)-induced mouse colitis model, metformin, an AMPK activator, could significantly inhibit the activation of IKK induced by DSS, thereby down-regulating the expression of the inflammatory factor IL-18 [15].